Raredr

Top Medical News Today

Venetoclax and Acute Myeloid Leukemia
The study found the drug to be safe and clinical remission was achieved in the majority of patients.
New Nitisinone Tablets Do Not Require Refrigeration
For quite some time, the only treatment option for people with hereditary tyrosinemia type 1 (HT-1) was SOBI’s Orfadin (nitisinone). That is changing.
Horizon's Shares Sink as Their Phase 3 Trial Didn't Meet Its Primary Endpoint
Horizon Pharma's shares are down due to their Phase 3 trial for the treatment of Friedreich’s ataxia not meeting its endpoint.
Jenkins' Departure for FDA not Sarepta or Trump Based
According to Jenkins, he has been thinking about leaving the FDA since 2015 but has stayed on to make sure that a person was in place to assume his responsibilities.
Vote Which #CuresNow Facebook Picture is The Best
RDR has compiled a few awesome photos from Facebook about the Cures Act and #CuresNow. Vote for your favorite photo!
Live Tweet Feed of #CuresNow
RDR presents a live Twitter feed of people talking about #CuresNow.
PTSD and depression in chronic blood disorders such as TTP
Shruti Chateurvedi and colleagues looked at the proportion of patients with thrombotic thrombocytopenic purpura who reported symptoms of depression and post-traumatic stress disorder (PTSD).
Is Whole Genome Sequencing Able to Diagnose 2 conditions in 1 person?
A new study published in the New England Journal of Medicine questions the ability of whole genome sequencing to be the best means to diagnose patients.
Senate Votes 94 – 4 in Favor of 21st Century Cures Act  #curesnow
The vote by the Senate was 94 – 5. Last week, Congress voted 392 – 26 in favor of the Bill.
Interferons and Myeloproliferative Neoplasms (MPNs)
Ruben Mesa, MD of the Mayo Clinic in Scottsdale Arizona talks about two approaches to treating polycythemia vera, and essential thrombocythemia that use interferons.
RareDR Resource Guide
$eventList$
$vacMongoViewPlus$ $vAR$